Asymptomatic bacteriuria Escherichia coli are live biotherapeutics for UTI.
Urinary tract infections (UTI) account for approximately 8 million clinic visits annually with symptoms that include acute pelvic pain, dysuria, and irritative voiding. Empiric UTI management with antimicrobials is complicated by increasing antimicrobial resistance among uropathogens, but live bioth...
Main Authors: | Charles N Rudick, Aisha K Taylor, Ryan E Yaggie, Anthony J Schaeffer, David J Klumpp |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4236008?pdf=render |
Similar Items
-
Evaluation of the efficacy of a live Escherichia coli biotherapeutic product (asymptomatic bacteriuria E. coli 212)
by: Gilad Segev, et al.
Published: (2024-09-01) -
Asymptomatic bacteriuria in recurrent UTI – to treat or not to treat
by: Cai, Tommaso, et al.
Published: (2017-12-01) -
Asymptomatic Bacteriuria in Clinical Urological Practice: Preoperative Control of Bacteriuria and Management of Recurrent UTI
by: Tommaso Cai, et al.
Published: (2016-01-01) -
Genotypic characteristics of Uropathogenic Escherichia coli isolated from complicated urinary tract infection (cUTI) and asymptomatic bacteriuria—a relational analysis
by: Lalitha Maniam, et al.
Published: (2023-06-01) -
Deliberate Establishment of Asymptomatic Bacteriuria—A Novel Strategy to Prevent Recurrent UTI
by: Björn Wullt, et al.
Published: (2016-07-01)